PUBLIC COMPANY
saveCipla Ltd
updated 3mo ago
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.
community read0 votes
🐶 often sniffed alongside
top 8- tagApproval16 co-mentions · 8 sources
- drugEllence7 co-mentions · 7 sources
- companyCipla USA Inc7 co-mentions · 5 sources
- drugEPIRUBICIN HYDROCHLORIDE7 co-mentions · 7 sources
- tagRecall5 co-mentions · 5 sources
- drugDAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE2 co-mentions · 1 sources
- drugDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE2 co-mentions · 1 sources
- drugDAPAGLIFLOZIN2 co-mentions · 1 sources
pipeline
0
marketed
0
phase 3
0
catalysts ytd
6
approvals ytd
6
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that